Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: investigation by a nickel mesh filtration technique
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Introduction: Hypertension is associated with microcirculatory disturbance, and erythrocyte deformability is a major determinant of the microcirculation. However, impairment of erythrocyte deformability in hypertensive patients in relation to antihypertensive treatment is unclear. The present study aimed to investigate this impairment in hypertensive patients under treatment using a highly sensitive and quantitative nickel mesh filtration technique. Methods: Deformability was evaluated by filterability, defined as the flow rate of a hematocrit-adjusted erythrocyte suspension relative to that of saline under a specific filtration pressure in a pressure-flow curve obtained by continuous filtration. Baseline characteristics of hypertensive patients (n = 101) and age-matched normotensive subjects (n = 14) were obtained from medical records, and diabetic patients were excluded. Results: Erythrocyte deformability in the hypertensive group was significantly (p = 0.010) lower (87.8 ± 2.2 %) than that of the normotensive group (89.4 ± 1.7 %) and inversely proportional (r = −0.303, p = 0.002) to the mean blood pressure (BP) measured on blood sampling for the filtration study. Stepwise multiple regression analysis demonstrated that this impairment was mostly attributable to the mean BP (p = 0.001), whereas current smoking and episodes of stroke or coronary artery disease were not contributors. Discussion: These findings indicate that erythrocyte deformability is impaired in the hypertensive patients, which depends on the current BP control rather than target organ damage.
Abstract
Introduction: Hypertension is associated with microcirculatory disturbance, and erythrocyte deformability is a major determinant of the microcirculation. However, impairment of erythrocyte deformability in hypertensive patients in relation to antihypertensive treatment is unclear. The present study aimed to investigate this impairment in hypertensive patients under treatment using a highly sensitive and quantitative nickel mesh filtration technique. Methods: Deformability was evaluated by filterability, defined as the flow rate of a hematocrit-adjusted erythrocyte suspension relative to that of saline under a specific filtration pressure in a pressure-flow curve obtained by continuous filtration. Baseline characteristics of hypertensive patients (n = 101) and age-matched normotensive subjects (n = 14) were obtained from medical records, and diabetic patients were excluded. Results: Erythrocyte deformability in the hypertensive group was significantly (p = 0.010) lower (87.8 ± 2.2 %) than that of the normotensive group (89.4 ± 1.7 %) and inversely proportional (r = −0.303, p = 0.002) to the mean blood pressure (BP) measured on blood sampling for the filtration study. Stepwise multiple regression analysis demonstrated that this impairment was mostly attributable to the mean BP (p = 0.001), whereas current smoking and episodes of stroke or coronary artery disease were not contributors. Discussion: These findings indicate that erythrocyte deformability is impaired in the hypertensive patients, which depends on the current BP control rather than target organ damage.
참고문헌 (25)
- Zullig LL., "The role of home blood pressure telemonitoring in managing hypertensive populations(Review)", Curr Hypertens Rep, 15, pp.346~355 (2013)
- Kaczmarska M., "Erythrocyte membrane properties in patients with essential hypertension", Cell Biochem Biophys, 67, pp.1089~1102 (2013)
- Amaiden MR., "Involvement of membrane tubulin in erythrocyte deformability and blood pressure", J Hypertens, 30, pp.1414~1422 (2012)
- Pytel E., "Disorders of erythrocyte structure and function in hypertensive patients", Med Sci Monit., 18, pp.BR331~BR336 (2012)
- Rodgers GP., "Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease", N Engl J Med, 328, pp.73~80 (1993)
- Hiruma H., "Contributions of sickle hemoglobin polymer and sickle cell membranes to impaired filterability", Am J Physiol, 268, pp.H2003~H2008 (1995)
- Oonishi T., "Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways", Am J Physiol., 273, pp.C1828~C1834 (1997)
- Saito K., "Impaired deformability of erythrocytes in diabetic rat and human : investigation by the nickel-mesh-filtration technique", J Biorheol, 25, pp.18~26 (2011)
- Ejima J., "Relationship of high-density lipoprotein cholesterol and red blood cell filterability : cross-sectional study of healthy subjects", Clin Hemorheol Microcirc, 22, pp.1~7 (2000)
- Arai K., "Further investigations of red cell deformability with nickel mesh", Biorheology, 27, pp.47~65 (1990)
- Nakamura T., "Rheologic and pathophysiologic significance of red cell passage through narrow pores", Blood Cells, 20, pp.151~165 (1994)
- Saito K., "Improvement of diabetic or obese patients’ erythrocyte deformability by the program of the brain-oriented obesity control system(BOOCS)", J Physiol Sci, 62, pp.445~451 (2012)
- Okamoto K., "Verapamil prevents impairment in filterability of human erythrocytes exposed to oxidative stress", Jpn J Physiol, 54, pp.39~46 (2004)
- Mohandas N., "Red cell deformability, membrane material properties and shape : regulation by transmembrane, skeletal and cytosolic proteins and lipids", Semin Hematol, 30, pp.171~192 (1993)
- Dikalov SI., "Role of mitochondrial oxidative stress in hypertension", Am J Physiol., 305, pp.H1417~H1427 (2013)
- Higashi Y., "Oxidative stress and endothelial dysfunction : clinical evidence and therapeutic implications(Review)", Trends Cardiovasc Med, 24, pp.165~169 (2014)
- Uyesaka N., "Effects of superoxide anions on red cell deformability and membrane proteins", Biorheology, 29, pp.217~229 (1992)
- Iwata H., "Effect of carbonyl compounds on red blood cells deformability", Biochem Biophys Res Comm, 321, pp.700~706 (2004)
- Luneva OG., "Ion transport, membrane fluidity and haemoglobin conformation in erythrocyte from patients with cardiovascular diseases : role of augmented plasma cholesterol", Pathophysiology, 14, pp.41~46 (2007)
- Schulz E., "Oxidative stress and endothelial dysfunction in hypertension", Hypertens Res, 34, pp.665~673 (2011)
- Ariyoshi K., "Impaired erythrocyte filterability of spontaneously hypertensive rats : investigation by nickel mesh filtration technique", Circ J, 74, pp.129~136 (2010)
- Fornal M., "Left ventricular geometry and rheological properties of erythrocytes in patients at cardiovascular disease risk", Clin Hemorheol Microcirc, 43, pp.203~208 (2009)
- Ogihara T., "Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications : a sub-analysis of the CASE-J trial", Hypertens Res, 32, pp.248~254 (2009)
- Nakashima T., "TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase", Hypertens Res (2015)[DOI]
- Marketou ME., "TLR2 and TLR4 gene expression in peripheral monocytes in nondiabetic hypertensive patients : the effect of intensive blood pressure-lowering", J Clin Hypertens, 14, pp.330~335 (2012)